Evolution of Marginal Zone Lymphoma Towards Myeloproliferative Disorder: A Case Report
Journal Title: Iranian Journal of Blood and Cancer - Year 2009, Vol 1, Issue 4
Abstract
This article has no abstract.
Authors and Affiliations
Abdessamad Arabi, M. Brahimi, M. A. Bekadja, D. Saidi, H. Touhami
Keywords
Related Articles
- EP ID EP382888
- DOI -
- Views 224
- Downloads 0
Treatment of a Child with Refractory Acute Myeloid Leukemia with Humanized Anti-CD33 Monoclonal Antibody: A Case Report and Review of Drug Development
Background: The induction chemotherapy regimen for acute myeloid leukemia has evolved as once induction is completed patients progress through the consolidation phase and achieve remission in 76% of cases. For patients w...
Prevalence of Delta Beta Thalassemia Minor in Southern Iran
Background: Hb A2 is elevated in subjects with beta thalassemia minor but small percent of carriers have normal Hb A2 with elevated levels of HbF (2-10%). This type of thalassemia is called delta beta thalassemia, and ca...
Prevalence of Diabetes Mellitus in Patients with Transfusion Dependent β Thalassemia
Introduction: Thalassemia is common in Iran. Appropriate therapy for this disease includes a regular blood transfusion and chelation therapy. However, patients will inevitably confront with side effects, particularly iro...
Different Stages of Platelet Adhesion to the Site of Vascular Injury
Platelet activation and adhesion to the site of vascular injury is a dynamic process comprising reversible and irreversible phases. Platelet adhesion typically occurs in a multi-step process similar to the selectin/integ...
Medium and High-Dose Methotrexate-Induced Toxicity in Children with Acute Lymphoblastic Leukemia
Background: Methotrexate has an important role in treatment of acute leukemia. We measured methotrexate level in CSF and blood of children with acute lymphoblastic leukemia to determine complications and outcomes. Materi...